NCT07069023

Brief Summary

This randomised controlled trial will investigate the effects of breathing exercises and Reiki on fatigue and nausea-vomiting symptoms in oncology patients. Data will be collected through face-to-face interviews using structured forms before the start of chemotherapy. To account for possible losses, 20 patients will be included in each intervention group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2024

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

May 21, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 16, 2025

Completed
Last Updated

July 16, 2025

Status Verified

May 1, 2025

Enrollment Period

6 months

First QC Date

May 21, 2025

Last Update Submit

July 7, 2025

Conditions

Keywords

Breath exercisereiki applicationtirednessnauseavomiting

Outcome Measures

Primary Outcomes (2)

  • Individual Introductory Information Form

    It was consists of questions such as socio-demographic characteristics such as age, marital status, chronic diseases, disease history, and type, stage, metastasis status, metastasis site, treatment status, nausea and vomiting

    6 WEEKS

  • Hirai Cancer Fatigue Scale

    The scale measures fatigue in cancer patients and is 5-point Likert type. The minimum value of the scale is 15 and the maximum value is 75. High scores on the scale indicate increased fatigue and low scores indicate decreased fatigue.The Cronbach Alpha value of the original scale was found to be 0.943.

    6 WEEKS

Study Arms (2)

reiki group

ACTIVE COMPARATOR

Oncology patients with nausea, vomiting and fatigue received reiki throughout the treatment.

Other: breathing exercise groupOther: reiki group

breathing exercise group

ACTIVE COMPARATOR

Oncology patients with nausea, vomiting and fatigue were given breathing exercises throughout the treatment.

Other: breathing exercise groupOther: reiki group

Interventions

Oncology patients with nausea, vomiting and fatigue were given breathing exercises throughout the treatment.

Also known as: control group
breathing exercise groupreiki group

Oncology patients with nausea, vomiting and fatigue received reiki throughout the treatment.

breathing exercise groupreiki group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sağlık Bilimleri Üniversitesi

Istanbul, 34255, Turkey (Türkiye)

Location

MeSH Terms

Conditions

NeoplasmsFatigueNauseaVomiting

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, Digestive

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Gamze Temiz

    Saglik Bilimleri Universitesi

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This study employed a three-group experimental design involving a breathing exercise group, a Reiki group, and a control group. Participants in the intervention groups received sessions twice a week for six weeks, while the control group received no intervention. Data were collected at three points: pre-test (week 1), mid-test (week 3), and post-test (week 6), using validated instruments. These assessments aimed to measure changes over time and compare group differences. Ethical approval was obtained, and informed consent was secured from all participants.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2025

First Posted

July 16, 2025

Study Start

December 1, 2023

Primary Completion

May 30, 2024

Study Completion

May 30, 2024

Last Updated

July 16, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations